248 related articles for article (PubMed ID: 37234002)
1. Current status and future challenges of genotoxicity OECD Test Guidelines for nanomaterials: a workshop report.
Doak SH; Andreoli C; Burgum MJ; Chaudhry Q; Bleeker EAJ; Bossa C; Domenech J; Drobne D; Fessard V; Jeliazkova N; Longhin E; Rundén-Pran E; Stępnik M; El Yamani N; Catalán J; Dusinska M
Mutagenesis; 2023 Aug; 38(4):183-191. PubMed ID: 37234002
[TBL] [Abstract][Full Text] [Related]
2. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines.
Warheit DB; Donner EM
Nanotoxicology; 2010 Dec; 4():409-13. PubMed ID: 20925448
[TBL] [Abstract][Full Text] [Related]
3. Developing OECD test guidelines for regulatory testing of nanomaterials to ensure mutual acceptance of test data.
Rasmussen K; Rauscher H; Kearns P; González M; Riego Sintes J
Regul Toxicol Pharmacol; 2019 Jun; 104():74-83. PubMed ID: 30831158
[TBL] [Abstract][Full Text] [Related]
4. The OECD expert meeting on ecotoxicology and environmental fate--towards the development of improved OECD guidelines for the testing of nanomaterials.
Kühnel D; Nickel C
Sci Total Environ; 2014 Feb; 472():347-53. PubMed ID: 24461369
[TBL] [Abstract][Full Text] [Related]
5. In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines.
Doak SH; Manshian B; Jenkins GJ; Singh N
Mutat Res; 2012 Jun; 745(1-2):104-11. PubMed ID: 21971291
[TBL] [Abstract][Full Text] [Related]
6. Regulatory ecotoxicity testing of nanomaterials - proposed modifications of OECD test guidelines based on laboratory experience with silver and titanium dioxide nanoparticles.
Hund-Rinke K; Baun A; Cupi D; Fernandes TF; Handy R; Kinross JH; Navas JM; Peijnenburg W; Schlich K; Shaw BJ; Scott-Fordsmand JJ
Nanotoxicology; 2016 Dec; 10(10):1442-1447. PubMed ID: 27592624
[TBL] [Abstract][Full Text] [Related]
7. Review of achievements of the OECD Working Party on Manufactured Nanomaterials' Testing and Assessment Programme. From exploratory testing to test guidelines.
Rasmussen K; González M; Kearns P; Sintes JR; Rossi F; Sayre P
Regul Toxicol Pharmacol; 2016 Feb; 74():147-60. PubMed ID: 26603783
[TBL] [Abstract][Full Text] [Related]
8. NAM-supported read-across: From case studies to regulatory guidance in safety assessment.
Rovida C; Escher SE; Herzler M; Bennekou SH; Kamp H; Kroese DE; Maslankiewicz L; Moné MJ; Patlewicz G; Sipes N; Van Aerts L; White A; Yamada T; Van de Water B
ALTEX; 2021; 38(1):140-150. PubMed ID: 33452529
[TBL] [Abstract][Full Text] [Related]
9. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
[TBL] [Abstract][Full Text] [Related]
10. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
11. Considerations on photochemical genotoxicity. II: report of the 2009 International Workshop on Genotoxicity Testing Working Group.
Lynch AM; Guzzie PJ; Bauer D; Gocke E; Itoh S; Jacobs A; Krul CA; Schepky A; Tanaka N; Kasper P
Mutat Res; 2011 Aug; 723(2):91-100. PubMed ID: 21296679
[TBL] [Abstract][Full Text] [Related]
12. Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations--many questions, some answers.
Landsiedel R; Kapp MD; Schulz M; Wiench K; Oesch F
Mutat Res; 2009; 681(2-3):241-258. PubMed ID: 19041420
[TBL] [Abstract][Full Text] [Related]
13. Strategy for genotoxicity testing--metabolic considerations.
Ku WW; Bigger A; Brambilla G; Glatt H; Gocke E; Guzzie PJ; Hakura A; Honma M; Martus HJ; Obach RS; Roberts S;
Mutat Res; 2007 Feb; 627(1):59-77. PubMed ID: 17141553
[TBL] [Abstract][Full Text] [Related]
14. Physico-chemical properties of manufactured nanomaterials - Characterisation and relevant methods. An outlook based on the OECD Testing Programme.
Rasmussen K; Rauscher H; Mech A; Riego Sintes J; Gilliland D; González M; Kearns P; Moss K; Visser M; Groenewold M; Bleeker EAJ
Regul Toxicol Pharmacol; 2018 Feb; 92():8-28. PubMed ID: 29074277
[TBL] [Abstract][Full Text] [Related]
15. Genotoxicity Assessment of Nanomaterials: Recommendations on Best Practices, Assays, and Methods.
Elespuru R; Pfuhler S; Aardema MJ; Chen T; Doak SH; Doherty A; Farabaugh CS; Kenny J; Manjanatha M; Mahadevan B; Moore MM; Ouédraogo G; Stankowski LF; Tanir JY
Toxicol Sci; 2018 Aug; 164(2):391-416. PubMed ID: 29701824
[TBL] [Abstract][Full Text] [Related]
16. Genotoxicity of nanomaterials: refining strategies and tests for hazard identification.
Pfuhler S; Elespuru R; Aardema MJ; Doak SH; Maria Donner E; Honma M; Kirsch-Volders M; Landsiedel R; Manjanatha M; Singer T; Kim JH
Environ Mol Mutagen; 2013 May; 54(4):229-39. PubMed ID: 23519787
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of U. S. National Toxicology Program (NTP) mouse lymphoma assay data using International Workshop on Genotoxicity Tests (IWGT) and the Organization for Economic Co-Operation and Development (OECD) criteria.
Schisler MR; Gollapudi BB; Moore MM
Environ Mol Mutagen; 2018 Dec; 59(9):829-841. PubMed ID: 30357906
[TBL] [Abstract][Full Text] [Related]
18. Accelerating the Pace of Chemical Risk Assessment.
Kavlock RJ; Bahadori T; Barton-Maclaren TS; Gwinn MR; Rasenberg M; Thomas RS
Chem Res Toxicol; 2018 May; 31(5):287-290. PubMed ID: 29600706
[TBL] [Abstract][Full Text] [Related]
19. FAIRification of nanosafety data to improve applicability of (Q)SAR approaches: A case study on
Bossa C; Andreoli C; Bakker M; Barone F; De Angelis I; Jeliazkova N; Nymark P; Battistelli CL
Comput Toxicol; 2021 Nov; 20():100190. PubMed ID: 34820591
[TBL] [Abstract][Full Text] [Related]
20. [International trend regarding immunotoxicity evaluation with New Approach Methods (NAMs)].
Kojima H; Ashikaga T
Nihon Yakurigaku Zasshi; 2022; 157(5):340-344. PubMed ID: 36047149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
